DaVita Kidney Care has announced the appointment of Mihran Naljayan—a clinical associate professor at LSU School of Medicine (New Orleans, USA) who is board-certified in nephrology and hypertension through the American Board of Internal Medicine—as its new chief medical officer (CMO) of home modalities.
Naljayan joined DaVita in 2016 and most recently served as vice president of clinical affairs within the company’s home dialysis programme. In that role, he created and led DaVita’s home physician support network—a programme intended to help empower nephrologists to advocate for home dialysis with eligible patients.
Since Naljayan joined DaVita, a company press release states, there has been a 35% increase in home haemodialysis and peritoneal dialysis treatments. He will continue to lead this initiative while expanding his scope as CMO of home modalities.
Naljayan succeeds Martin Schreiber, who has led DaVita’s home dialysis programme since 2014. Schreiber will continue to serve DaVita’s home patients in a part-time capacity as a consultant for several strategic initiatives, including DaVita’s 11 newly launched, value-based care programmes that aim to increase access to home dialysis.
“I have deep gratitude for the countless physicians and patients Dr Schreiber has inspired to become advocates for home treatments,” said Naljayan. “It is an honour to build on the foundation he set, and further support physicians and patients who want to experience the benefit of treating at home.”